Relevance of cost-effectiveness analysis to clinicians and policy makers
JAMA
.
2007 Jul 11;298(2):221-4.
doi: 10.1001/jama.298.2.221.
Authors
Allan S Detsky
1
,
Andreas Laupacis
Affiliation
1
Department of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada. allan.detsky@uhn.on.ca
PMID:
17622605
DOI:
10.1001/jama.298.2.221
No abstract available
MeSH terms
Biomedical Technology / economics*
Biomedical Technology / trends
Cost-Benefit Analysis
Decision Support Techniques
Models, Economic
Policy Making
Quality-Adjusted Life Years